These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

191 related items for PubMed ID: 9334468

  • 21. Adverse reactions to trimethoprim-sulfamethoxazole.
    Lee BL.
    Clin Rev Allergy Immunol; ; 14(4):451-5. PubMed ID: 9040971
    [No Abstract] [Full Text] [Related]

  • 22. Cost-effectiveness of prophylaxis against Pneumocystis carinii pneumonia in patients with Wegner's granulomatosis undergoing immunosuppressive therapy.
    Chung JB, Armstrong K, Schwartz JS, Albert D.
    Arthritis Rheum; 2000 Aug; 43(8):1841-8. PubMed ID: 10943875
    [Abstract] [Full Text] [Related]

  • 23. [Allergy to trimethoprim-sulfamethoxazole in normal, atopic and immunodepressed subjects].
    Pioda GB, Del Favero A, Menichetti F, Spinozzi F, Gernini I, Rambotti P.
    Clin Ter; 1987 Aug 15; 122(3):171-5. PubMed ID: 2973909
    [No Abstract] [Full Text] [Related]

  • 24. Hyperkalemic renal tubular acidosis induced by trimethoprim/sulfamethoxazole in an AIDS patient.
    Sheehan MT, Wen SF.
    Clin Nephrol; 1998 Sep 15; 50(3):188-93. PubMed ID: 9776424
    [Abstract] [Full Text] [Related]

  • 25. [Immuno-allergic reactions to cotrimoxazole in a hospital population].
    Pioda GB, Del Favero A, Guerciolini R, Menichetti F, Gernini I, Rambotti P.
    Quad Sclavo Diagn; 1987 Mar 15; 23(1):24-31. PubMed ID: 3502028
    [Abstract] [Full Text] [Related]

  • 26. Efficacy and safety of desensitization with sulfamethoxazole and trimethoprim in 48 previously hypersensitive patients infected with human immunodeficiency virus.
    Caumes E, Guermonprez G, Lecomte C, Katlama C, Bricaire F.
    Arch Dermatol; 1997 Apr 15; 133(4):465-9. PubMed ID: 9126010
    [Abstract] [Full Text] [Related]

  • 27. Trimethoprim-sulfamethoxazole desensitization in AIDS.
    Papakonstantinou G, Füessl H, Hehlmann R.
    Klin Wochenschr; 1988 Apr 15; 66(8):351-3. PubMed ID: 3260637
    [Abstract] [Full Text] [Related]

  • 28. [Trimethoprim-sulfamethoxazole as antibacterial prophylaxis during induction therapy of children with acute lymphatic leukemia].
    Agger KE, Schrøder H, Rosthøj S, Carlsen NT, Schmiegelow K.
    Ugeskr Laeger; 2002 Jan 21; 164(4):488-92. PubMed ID: 11838420
    [Abstract] [Full Text] [Related]

  • 29. Adverse reactions to sulphonamide and sulphonamide-trimethoprim antimicrobials: clinical syndromes and pathogenesis.
    Cribb AE, Lee BL, Trepanier LA, Spielberg SP.
    Adverse Drug React Toxicol Rev; 1996 Mar 21; 15(1):9-50. PubMed ID: 8920632
    [No Abstract] [Full Text] [Related]

  • 30. The acquired immunodeficiency syndrome and a trimethoprim-sulfamethoxazole adverse reaction.
    Cohn DL, Penley KA, Judson FN, Kirkpatrick CH, Horsburgh CR, Davis KC.
    Ann Intern Med; 1984 Feb 21; 100(2):311. PubMed ID: 6607009
    [No Abstract] [Full Text] [Related]

  • 31. Newly diagnosed human immunodeficiency virus after sepsis-like reaction of trimethoprim-sulfamethoxazole.
    Moran KA, Ales NC, Hemmer PA.
    South Med J; 2001 Mar 21; 94(3):350-2. PubMed ID: 11284528
    [Abstract] [Full Text] [Related]

  • 32. AIDS and pure red cell aplasia.
    Stricker RB, Goldberg B.
    Am J Hematol; 1997 Mar 21; 54(3):264. PubMed ID: 9067509
    [No Abstract] [Full Text] [Related]

  • 33. Trimethoprim-sulfamethoxazole-induced sepsis-like syndrome in a patient with AIDS.
    O'Kane EB, Schneeweiss R.
    J Am Board Fam Pract; 1996 Mar 21; 9(6):448-50. PubMed ID: 8923404
    [No Abstract] [Full Text] [Related]

  • 34. Trimethoprim-sulfamethoxazole treatment does not reverse obstructive pulmonary changes in pneumocystis-colonized nonhuman primates with SHIV infection.
    Kling HM, Shipley TW, Guyach S, Tarantelli R, Morris A, Norris KA.
    J Acquir Immune Defic Syndr; 2014 Apr 01; 65(4):381-9. PubMed ID: 24121760
    [Abstract] [Full Text] [Related]

  • 35. [Pneumocystosis of splenic localization in the course of HIV infection: a new indication for splenectomy. Description of a case].
    Galimberti A, Morandi E, Giani G, Vitri P, Piraneo S, De Pasquale L, Bastagli A.
    Ann Ital Chir; 1997 Apr 01; 68(4):559-62; discussion 562-3. PubMed ID: 9494189
    [Abstract] [Full Text] [Related]

  • 36. Ineffectiveness of trimethoprim-sulfamethoxazole prophylaxis and the importance of bacterial and viral coinfections in African children with Pneumocystis carinii pneumonia.
    Madhi SA, Cutland C, Ismail K, O'Reilly C, Mancha A, Klugman KP.
    Clin Infect Dis; 2002 Nov 01; 35(9):1120-6. PubMed ID: 12384847
    [Abstract] [Full Text] [Related]

  • 37. Is hydroxylamine-induced cytotoxicity a valid marker for hypersensitivity reactions to sulfamethoxazole in human immunodeficiency virus-infected individuals?
    Reilly TP, MacArthur RD, Farrough MJ, Crane LR, Woster PM, Svensson CK.
    J Pharmacol Exp Ther; 1999 Dec 01; 291(3):1356-64. PubMed ID: 10565861
    [Abstract] [Full Text] [Related]

  • 38. A prospective randomized trial comparing the toxicity and safety of atovaquone with trimethoprim/sulfamethoxazole as Pneumocystis carinii pneumonia prophylaxis following autologous peripheral blood stem cell transplantation.
    Colby C, McAfee S, Sackstein R, Finkelstein D, Fishman J, Spitzer T.
    Bone Marrow Transplant; 1999 Oct 01; 24(8):897-902. PubMed ID: 10516703
    [Abstract] [Full Text] [Related]

  • 39. Discontinuation of primary prophylaxis for Pneumocystis carinii pneumonia and toxoplasmic encephalitis in human immunodeficiency virus type I-infected patients: the changes in opportunistic prophylaxis study.
    Mussini C, Pezzotti P, Govoni A, Borghi V, Antinori A, d'Arminio Monforte A, De Luca A, Mongiardo N, Cerri MC, Chiodo F, Concia E, Bonazzi L, Moroni M, Ortona L, Esposito R, Cossarizza A, De Rienzo B.
    J Infect Dis; 2000 May 01; 181(5):1635-42. PubMed ID: 10823763
    [Abstract] [Full Text] [Related]

  • 40. Trimethoprim-sulfamethoxazole (TMP-SMZ) dose escalation versus direct rechallenge for Pneumocystis Carinii pneumonia prophylaxis in human immunodeficiency virus-infected patients with previous adverse reaction to TMP-SMZ.
    Leoung GS, Stanford JF, Giordano MF, Stein A, Torres RA, Giffen CA, Wesley M, Sarracco T, Cooper EC, Dratter V, Smith JJ, Frost KR, American Foundation for AIDS Research (amfAR) Community-Based Clinical Trials Network.
    J Infect Dis; 2001 Oct 15; 184(8):992-7. PubMed ID: 11574913
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.